搜索
产品
社区
市场
新闻
经纪商
更多
CN
开始
CRSP- Pioneer and leader in gene editing
CRISPR Therapeutics AG
(
NASDAQ:CRSP
)
Libratus
NASDAQ:CRSP
CRISPR Therapeutics AG
Trend Analysis
Technical Indicators
Fundamental Analysis
CRSP
crspr
geneediting
EDIT
NTLA
beam
2
0
trendanalysis
indicator
fundamental
crsp
crspr
geneediting
edit
ntla
beam
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain.
I think it has one more leg down. Accumulate in the demand zone.
相关观点
ILMN- Leader in gene sequencing
Libratus
about
ILMN
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在
使用条款
阅读更多信息。